Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C26655
http://purl.obolibrary.org/obo/NCIT_C26655
|
|---|---|
| Preferred Name | Forodesine Hydrochloride |
| Definitions |
The hydrochloride salt of the synthetic high-affinity transition-state analogue forodesine. Forodesine binds preferentially to and inhibits purine nucleotide phosphorylase (PNP), resulting in the accumulation of deoxyguanosine triphosphate and the subsequent inhibition of the enzyme ribonucleoside diphosphate reductase and DNA synthesis. This agent selectively causes apoptosis in stimulated or malignant T-lymphocytes. A transition state analogue is a substrate designed to mimic the properties or the geometry of the transition state of reaction.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | The hydrochloride salt of the synthetic high-affinity transition-state analogue forodesine. Forodesine binds preferentially to and inhibits purine nucleotide phosphorylase (PNP), resulting in the accumulation of deoxyguanosine triphosphate and the subsequent inhibition of the enzyme ribonucleoside diphosphate reductase and DNA synthesis. This agent selectively causes apoptosis in stimulated or malignant T-lymphocytes. A transition state analogue is a substrate designed to mimic the properties or the geometry of the transition state of reaction. |
|---|---|
| prefLabel | Forodesine Hydrochloride
|
| label | Forodesine Hydrochloride
|
| PDQ_Closed_Trial_Search_ID | 301648
|
| code | C26655
|
| Has_Target | |
| prefixIRI | NCIT:C26655
|
| in_subset |
See more
See less
|
| Display_Name | Forodesine Hydrochloride
|
| Preferred_Name | Forodesine Hydrochloride
|
| FDA_UNII_Code | 6SN82Y9U73
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C11H14N4O4.HCl
|
| Maps_To | Forodesine Hydrochloride
|
| CAS_Registry | 284490-13-7
|
| NCI_Drug_Dictionary_ID | 301648
|
| Legacy Concept Name | Immucillin-H
|
| Has_Free_Acid_Or_Base_Form | |
| type | |
| ALT_DEFINITION | A substance being studied in the treatment of some types of leukemia and lymphoma. It is a type of purine nucleoside phosphorylase (PNP) inhibitor.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 301648
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C1175653
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |